INTREPID BIOSCIENCES

Serial Number 97263723
606

Registration Progress

Application Filed
Feb 11, 2022
Under Examination
Mar 14, 2023
Approved for Publication
Jan 17, 2023
Published for Opposition
Jan 17, 2023
Registered

Trademark Image

INTREPID BIOSCIENCES

Basic Information

Serial Number
97263723
Filing Date
February 11, 2022
Published for Opposition
January 17, 2023
Abandonment Date
October 16, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 16, 2023
Classes
005 042

Rights Holder

Intrepid Biosciences, Inc.

03
Address
Suite 1202
555 Madison Ave.
New York, NY 10022

Ownership History

Intrepid Biosciences, Inc.

Original Applicant
03
New York, NY

Intrepid Biosciences, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Heather E. Balmat

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Oct 16, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 16, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 14, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 9, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 9, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 9, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 5, 2022 CPRA R PRIORITY ACTION WRITTEN Loading...
Dec 5, 2022 GPRA F PRIORITY ACTION E-MAILED Loading...
Dec 5, 2022 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Nov 28, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceuticals for the treatment of autoimmune diseases
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
development for pharmaceutical preparations for the treatment of autoimmune diseases; scientific and clinical research, namely, drug development research in the field of autoimmune diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOSCIENCES"